Originally published In Press as doi:10.1074/jbc.M200174200 on February 20, 2002
J. Biol. Chem., Vol. 277, Issue 19, 16489-16497, May 10, 2002
Comparison of the Post-transcriptional Regulation of the
mRNAs for the Surface Proteins PSA (GP46) and MSP (GP63) of
Leishmania chagasi*
Karen S.
Myung
§,
Jeffrey K.
Beetham
¶,
Mary E.
Wilson§
**
, and
John E.
Donelson
§§§
From the Departments of
Biochemistry,
Microbiology, and ** Internal Medicine and the
§ Medical Scientist Training Program, University of Iowa and
the 
Veterans Affairs Medical Center,
Iowa City, Iowa 52242
Received for publication, January 8, 2002, and in revised form, February 1, 2002
 |
ABSTRACT |
MSP (GP63) and PSA (GP46) are abundant 63- and
46-kDa glycolipid-anchored proteins on the surface of the promastigote
form of most Leishmania species. MSP is a zinc
metalloprotease that confers resistance to host complement-mediated
lysis. PSA contains internal repeats of 24 amino acids, and its
function is unknown. The steady state levels of mRNAs for both
glycoproteins are regulated post-transcriptionally, resulting in about
a 30-fold increase as Leishmania chagasi promastigotes grow
in vitro from logarithmic phase to stationary phase.
Previous studies showed the 3'-untranslated regions (3'-UTRs) of these
mRNAs are essential for this post-transcriptional regulation. These
two 3'-UTRs of 1.0 and 1.3 kilobases were cloned immediately downstream
of a
-galactosidase reporter gene in a plasmid, and segments were
systematically deleted to examine which portions of the 3'-UTRs
contribute to the post-transcriptional regulation. The 92-nucleotide
segment of greatest similarity between the two 3'-UTRs was deleted
without loss of regulation, but the segments flanking this similarity
region have positive regulatory elements essential for the regulation.
We propose that similar, but non-identical, molecular mechanisms
regulate the parallel expression of these two L. chagasi
mRNAs despite their lack of sequence identity. These
post-transcriptional mechanisms resemble the mechanism recently
suggested for the regulation of mRNAs encoding the dipeptide
(EP) and pentapeptide (GPEET) repeat proteins in Trypanosoma
brucei that involves interactions between positive and negative
regulatory elements in the 3'-UTR.
 |
INTRODUCTION |
Protozoan parasites of the genus Leishmania cause a
diverse group of diseases collectively called leishmaniasis that range in severity from spontaneously healing cutaneous ulcers to potentially fatal visceral disease. During their life cycle the
Leishmania sp. exist as two developmental stages,
i.e. as extracellular promastigotes in the gut of the
sandfly vector and as intracellular amastigotes in the phagolysosome of
mammalian macrophages. Glycoproteins on the surface of the organism
play important roles in its survival in both of these environments. The
two best characterized Leishmania surface glycoproteins are
the major surface protease
(MSP,1 also called GP63 for
63-kDa glycoprotein) and the parasite surface antigen (PSA, also named GP46 for 46-kDa glycoprotein).
Although these proteins have historically been called GP63 and GP46,
the Nomenclature Working Group for Protozoan Parasites has recommended that protozoan proteins be assigned 3-6-letter names (1), so we will
use the nomenclature of MSP and PSA here. Immunization with recombinant
versions of either of these proteins or their genes via DNA vaccines
provides experimental animals with partial protection against
Leishmania challenge (2-6).
Leishmania MSP is a family of closely related zinc
metalloproteases that have been found in different reports to (i)
confer resistance of promastigotes to complement-mediated lysis (7), (ii) promote attachment to and internalization of promastigotes by host
macrophages (8), and (iii) facilitate the intracellular survival of
amastigotes in phagolysosomes of host macrophages (9). When virulent
promastigotes develop during growth in culture from the less infectious
logarithmic phase to the highly infectious stationary form, an
11-30-fold increase in MSP expression occurs (10-12). In
Leishmania chagasi, which causes visceral leishmaniasis in
Latin America, MSP is encoded by more than 18 genes (MSPs) that fall into three classes on the basis of (i) the stage at which
they are expressed in the life cycle and (ii) unique sequences in their
3'-untranslated regions (UTRs) and intergenic regions (IRs) (13). In
virulent promastigotes, 3.0-kb MSPS RNAs are expressed in
stationary (S) phase but not logarithmic phase of growth,
whereas 2.7-kb MSPL RNAs are expressed during logarithmic (L) but not stationary phase. MSPC RNAs of 2.6 and 3.1 kb are constitutively (C) expressed at low levels in
both logarithmic and stationary phase (14).
PSA is another family of closely related proteins that have been
detected in all Leishmania species examined except for
members of the Leishmania braziliensis complex (15-18). All
reported nascent PSA sequences contain hydrophobic amino- and carboxyl
termini that are likely cleaved during translocation of the protein
across the endoplasmic reticulum and its linkage to a glycolipid
anchor. The function(s) of PSAs is not known, but they possess 3-13
internal leucine-rich repeats of 24 amino acids that have been shown in other proteins to participate in protein-protein interactions (19). The
organization of the PSA genes (PSAs) has not been fully
characterized in any Leishmania species, but in those that have been investigated the multiple non-identical PSAs occur
in clusters (18-20). In L. chagasi promastigotes,
expression of the 2.8-kb PSA mRNA parallels that of
3.0-kb MSPS mRNA during growth in vitro. The
steady state levels of both RNA species increase more than 30-fold as
the promastigotes develop from the less infectious, logarithmic form to
the highly infectious, stationary form (20). Stationary promastigotes
have approximately equal amounts of the PSA and
MSP RNAs, which together constitute 2-3% of the total mRNA in the cell.
Leishmania and other trypanosomatids do not appear to have
promoters for RNA polymerase II, which transcribes protein-encoding genes, even though transcription of these genes is sensitive to
-amanitin as it is in other eukaryotes (21). Instead, these genes
are constitutively transcribed from large gene clusters, and the steady
state levels of their mature mRNAs are regulated post-transcriptionally by mechanisms that often involve their 3'-UTR
sequences (22-28). Because the abundance of the PSA and MSPS RNAs in L. chagasi promastigotes are
regulated in parallel, we inspected their 3'-UTRs to see if their
1.0-kb (MSP) and 1.3-kb (PSA) 3'-UTRs contain
sequences in common. The greatest similarity between these two 3'-UTRs
is a 92-nucleotide segment with 66% identity. We found, using a
-galactosidase reporter gene, that neither this 92-nucleotide 3'-UTR
segment nor the downstream IR between the tandem MSPs or
PSAs contributes directly to the regulation of these two RNA
species. Therefore, we generated systematic deletions of other segments
of the two 3'-UTRs. We discovered that the regions immediately flanking
this 92-nucleotide segment are involved in regulating the levels of
both the MSPS and PSA mRNAs through similar, but non-identical, mechanisms. These mechanisms have features in common
with a recently proposed model for the regulation of the
Trypanosoma brucei genes for EP and GPEET, the most abundant proteins on the surface of the insect form of African trypanosomes (29-32).
 |
EXPERIMENTAL PROCEDURES |
Parasites--
A strain of L. chagasi
(MHOM/BF/00/1669) was originally isolated from a Brazilian patient with
visceral leishmaniasis. Virulent parasites were maintained in golden
hamsters, and amastigotes were isolated from infected hamster spleens.
Amastigotes convert into promastigotes when cultivated in
vitro at 26 °C in hemoflagellate-modified minimal essential
medium supplemented with 10% heat-inactivated fetal bovine serum and
5.6 µg hemin/ml at pH 7.4 (33). For most experiments, promastigote
cultures were seeded at 1 × 106 parasites/ml, and
stationary phase was achieved in 7-8 days. Logarithmic and stationary
phase were defined according to concentration and morphologic changes
as described (34). Promastigote cultures used for stable transfections
were used within 3 weeks of isolation from a hamster. The medium used
for selection and maintenance of stably transfected promastigotes
contained 50 µg of G418/ml (Invitrogen). All frozen stocks of
promastigotes were prepared within two passages in liquid media after
clonal isolation to avoid the effects of attenuation due to long term
serial passaging in culture.
For subsequent analyses, aliquots of ~1.5 × 108
promastigotes were removed either daily or during logarithmic (day 3)
and stationary (day 7) phases of growth. Parasites were washed in
sterile Dulbecco's phosphate-buffered saline (1×) (Invitrogen) 3 times by centrifugation for 5 min at 4000 × g, then
resuspended in 1.4 ml of phosphate-buffered saline (1×). The final
cell pellet was frozen in a dry ice/ethanol bath and stored at
70 °C. Cells for northern, Southern, and enzymatic analyses were
harvested separately from the same tissue culture flask for each stage
of growth. Cell densities were measured to confirm the stage of growth
because the duration of the lag phase and the growth rates vary
slightly from experiment to experiment. Data collected from each cell
line represent multiple transfections with the same plasmid to minimize
variability due to the particular condition of the parasites isolated
from different hamsters.
Plasmid Constructions--
The Leishmania expression
vector, pX
GAL2, was kindly provided by Stephen Beverley
(36). In earlier studies, plasmids were constructed in which the
corresponding 3'-UTRs and IR regions of the three MSP gene
classes, i.e. MSPS, MSPL, and
MSPC, were cloned at the XbaI site downstream of
the
GAL-coding region in pX
GAL2 (36, 37). A
fragment containing the 3'-UTR and IR of an L. chagasi
PSA gene, called PSAA, was isolated by NotI
digestion of a genomic DNA phage clone and ligated into a
NotI site downstream of the
GAL gene in
pX
GAL2. Recombinant constructs containing mutations in
these 3'-UTRs were initially constructed in pBluescript, after which
the mutant 3'-UTRs were gel-purified and cloned downstream of
GAL in pX
GAL2. Nucleotide sequences and
orientations were confirmed by DNA sequencing.
The plasmids used in the 3'-UTR and IR swapping experiments (Fig. 1)
and the 3'-UTR deletion experiments (Figs. 2, 4, 6, and 8) were derived
from the above-described plasmids containing the full PSAA
and MSPL 3'-UTR and IRs using spliced overlap extension (SOE) PCR (38) followed by appropriate restriction enzyme digestion and
ligation. The SOE PCR strategy facilitated the specific deletion of
nucleotides from large plasmids in which removal by restriction enzyme
digestion was limited. The primers used for the deletion constructs are
shown in Figs. 3 and 7. Some primers were designed to create a unique
AvrII site (5'-CCTAGG) at the site of deletion to facilitate
the insertion of non-leishmanial DNA sequences.
Replacement constructs were prepared in which non-leishmanial linker
DNA sequence and/or wild type sequence was inserted at the location of
the deletion in the deletion constructs. The inserted non-leishmanial
DNA sequence was selected to conserve length and GC nucleotide content.
The template for these PCR reactions was the pBluescript polylinker
region. PCR products were digested with AvrII and ligated
into this unique restriction site in the pX
GAL2 construct
at the deletion. Constructs A
3A and A
3B
(Fig. 4) were generated from A
3 by constructing a fusion
between part of the wild type region 3 sequence and the non-leishmanial
sequence (pBluescript). The resulting recombinant fragment was then
ligated into A
3 at the unique AvrII site at
the deletion. Deletions in the 3'-UTR of MSPS (Figs. 7 and
8) were made by the same SOE PCR procedures as those described above
for the deletions in the 3'-UTR of PSAA.
Generation and Activity Assays of Stable
Tranfectants--
L. chagasi promastigotes were stably
transfected and cloned according to the published protocol (33), a
procedure that took an average of 2-3 months to obtain each stably
transfected clone. Transfected cells were harvested, and cell pellets
were resuspended in 100 ml of lysis buffer (100 mM KH2PO4, pH 7.8, 0.33% Triton X-100), lysed by three freeze-thaw cycles, sonicated for
5 min, and centrifuged for 5 min at 10,000 × g. The
supernatant was assayed for protein concentration (bicinchoninic acid
reagent and assay, Pierce) and
GAL activity (using
Galacton-Star chemiluminescent substrate, CLONTECH,
Palo Alto, CA). Fluorescence was measured in triplicate in a Monolight
2010 luminometerTM (Analytical Luminescence Laboratory, San Diego, CA).
Data from each experimental clone were normalized to a control
transfectant containing the parent plasmid, pX
GAL2, to
eliminate variability due to differences in isolates and growth
conditions. Multiple clones from each transfection condition were used
in assays to establish consistency among different clones.
Calculations and Statistics--
GAL activities
for each transfectant were recorded as the average of three readings at
a 1:10 dilution of cell lysate as prepared above. Total protein
concentrations were recorded in µg/µl. Relative fluorescence units
(RFU) were calculated as (
GAL activity/µl of cell
lysate assayed)/1000. RFU/µg of total protein was then calculated as
(RFU/µl of supernatant)/(protein concentration in µg/µl).
RFU/µg of protein for each transfectant was normalized to the RFU for
the control transfectant containing the parent plasmid. The ratios of
normalized stationary phase activity to normalized logarithmic phase
activity were calculated for each transfectant. Figures contain the
means ± S.D. of these normalized RFUs and stationary/log (S/L)
ratios. The latter are referred to as the mean normalized S/L
GAL values. Statistical comparisons were done using
Student's t test with SigmaStat® software
(version 2.03, SPSS Inc.).
 |
RESULTS |
The 3'-UTR of PSAA (3'-UTRPSAA), but not Its Downstream
IR, Influences Expression of a
GAL Reporter Gene--
We previously
cloned the 3'-UTRs and downstream IRs of the three L. chagasi MSP gene classes, MSPS, MSPL,
and MSPC, and of a specific L. chagasi PSA gene,
PSAA, downstream of
GAL in the Leishmania expression plasmid, pX
GAL2 (36), and examined
their effects on
GAL expression (20, 37). Constructs of
the different plasmids were transfected into virulent L. chagasi promastigotes, and cloned transfectants were grown from
logarithmic to stationary phase in vitro. Samples were
removed at different times of growth for determination of
GAL enzyme activities and
GAL RNA levels. These experiments showed that expression of
GAL mRNA
and activity closely paralleled expression of the MSPS,
MSPL, or PSA whose 3'-UTR + IR was cloned
downstream of
GAL. For example, when the 3'-UTR + IR of
MSPS or PSAA was after
GAL, the
GAL activities and RNA levels were low in logarithmic
phase and steadily increased to 20-30-fold higher as the recombinant
promastigotes grew to stationary phase (20). In contrast, when the
3'-UTR + IR of MSPL was inserted after
GAL,
GAL expression remained at a low basal level throughout
promastigote growth even though the wild type MSPL RNA is
expressed more highly in logarithmic than in stationary growth (20).
Southern blots and nuclear run-on assays were used to show that in
these cloned stable transfectants the
GAL gene copy
number does not change during promastigote growth in culture under
constant drug selection and that the pX vector sequences are
constitutively transcribed (shown in Refs. 20 and 39).
To determine whether either the 3'-UTR or IR or both are the sequences
responsible for the growth-associated regulation of PSAA, we
first "swapped" the 3'-UTRs and IRs of PSAA and
MSPL, as shown in Fig. 1.
Plasmid constructs were made in which the
GAL-coding
region in plasmid pX
GAL2 was followed either by
3'-UTRPSAA + IRMSPL or by
3'-UTRMSPL + IRPSAA (see
"Experimental Procedures"). These linearized constructs were stably
transfected into virulent L. chagasi promastigotes. The
GAL activities and RNA levels in these cloned cells in
logarithmic (3 days of growth) versus stationary phase (7 days of growth) were compared with the corresponding constructs
containing
GAL followed by the complete 3'-UTR + IR of
either PSAA or MSPL (Fig. 1).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
3'-UTR and IR swapping experiments showing
that cis-regulatory elements reside in the 3'-UTR of
PSAA, not the IR. Promastigotes were stably
transfected with derivatives of pX GAL2 in which the
sequences cloned immediately downstream of GAL were as
illustrated schematically. Large open rectangles represent
the GAL-coding region. Large solid rectangles
are 3'-UTR sequences, and thin solid rectangles are IR
sequences. GAL activities (RFU/µg of protein) in
logarithmic (L) and stationary (S) phase cells
were measured and normalized to the activity of a transfectant
containing the parent plasmid in the same growth phase (as detailed
under "Experimental Procedures"). The ratios of these normalized
GAL activities in stationary versus
logarithmic phase transfectants (S/L) were calculated and are shown for
each transfectant (left column of numbers). RNAs
were isolated from the same transfectants and probed in Northern blots
with the GAL-coding sequence to determine the S/L ratio
of steady state RNA levels (right column of
numbers). Signals in the Northern blots were quantitated by
instant image analyses.
|
|
The ratio of
GAL activity in stationary versus
logarithmic cells (S/L in Fig. 1) was about 30 when the 3'-UTR + IR of
PSAA was after
GAL. The ratio was unchanged
when
GAL was followed by
3'-UTRPSAA + IRMSPL. In
each case, the 30-fold increase in
GAL activity in
stationary cells compared with logarithmic cells was accompanied by a
corresponding increase in the
GAL RNA steady state level,
as measured by instant imager analyses of Northern blots (summarized in
the right-hand column of Fig. 1) and as demonstrated previously for
PSAA (20). In contrast, when
GAL was followed
either by 3'-UTRMSPL + IRMSPL or by 3'-UTRMSPL + IRPSAA, the S/L ratio of both
GAL
activity and
GAL RNA was less than one. Thus, the 3'-UTR
sequence appears to account in large part for the increased expression
of PSAA and the lack of change in MSPL RNA during
the logarithmic-to-stationary transition. In contrast, the downstream
IR sequences do not appear to play a role. A further conclusion from
both these results and earlier results (20, 37) is that
GAL activity reflects the steady state level of
GAL RNA in these constructs containing downstream
PSAA and MSPS sequences
Deletion of a 92-Nucleotide Segment of Sequence Similarity in the
3'-UTRs of PSAA and MSPL Does Not Affect Gene
Regulation--
Previously we showed that the steady state levels of
both PSAA and MSPS RNAs increase in parallel as
virulent promastigotes grow from logarithmic to stationary phase (20).
We also showed that, similar to the 3'-UTRPSAA
results above, the increase in the MSPS RNA abundance is
regulated primarily by elements in the
3'-UTRMSPS (37). We therefore inspected the
1.3-kb 3'-UTRPSAA and the 1.0-kb
3'-UTRMSPL for shared sequence elements (Fig.
2A). The region of greatest similarity is a 92-nucleotide segment of 66% identity called the overlap or olp region. Two other small (<10 bp) regions of limited similarity are located upstream of olp. To see if this similar 92-nucleotide olp segment in each of the two 3'-UTRs contributes to the
parallel regulation of their RNAs, the 92 nucleotides were deleted from
each 3'-UTR by the SOE PCR technique (see "Experimental Procedures"), and the resultant
olp 3'-UTR + IR was cloned
immediately downstream of
GAL in pX
GAL2 for
subsequent stable transfections and
GAL activity
measurements.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Alignment of the segments with the most
sequence similarity (olp) in the
3'-UTRPSAA and 3'-UTRMSPS and the
GAL activities of promastigotes stably
transfected with constructs in which olp is
deleted. A, in the two schematic diagrams representing
PSAA and MSPS, the large open
rectangles depict the coding regions, and the thin gray
rectangles show the 3'-UTRs of PSAA and
MSPS. The smaller rectangles within the two
3'-UTRs indicate the segments of greatest 3'-UTR similarity. The
largest region of similarity is 92 nucleotides with 66% identity.
These segments are located 416 bp (PSAA) and 213 bp
(MSPS) upstream of the polyadenylation sites.
Nucleotide numbers indicate nucleotide positions in
full-length PSAA and MSPS cDNAs.
B, the results from GAL assays are shown for
the indicated transfectants as described in the text. The letter
A indicates the presence of an AvrII site at the
location of the olp deletion. N is the number of independent
experiments in which data were obtained for each transfected cell line.
For each experiment, the RFU/µg of protein for each transfectant were
normalized to the values for the transfectant containing the parent
plasmid at the same phase of growth (which was included in each
experiment). The mean normalized GAL S/L ratio ±S.D. was
calculated as described under "Experimental Procedures." The S.D.
was calculated using SigmaStat® statistical
software.
|
|
Fig. 2B shows that deletion of this olp region from these
two 3'-UTRs had little if any effect on the regulatory role of either 3'-UTR. The S/L
GAL activity ratio was about 30 ± 3.5 when the 3'-UTRPSAA was present and about
46 ± 16 when the 3'-UTRPSAA
olp was
present, yielding a statistically insignificant p value of 0.155. Likewise, the S/L
GAL ratio was about 63 ± 9 and 59 ± 15 in the presence of the
3'-UTRMSPS and
3'-UTRMSPS
olp, respectively. Thus, by this
targeted deletion analysis it appears the 3'-UTRs do not need the olp
segment to up-regulate their RNA levels during growth to stationary
phase. This conclusion prompted us to conduct a more systematic
deletion analysis of the two 3'-UTRs.
Specific Segments of the 3'-UTRPSAA Are Involved in
Gene Regulation--
Because deletion of the olp segment did not
abrogate logarithmic-stationary gene regulation, we used RNA secondary
structure prediction programs to examine the 3'-UTRs of PSAA
and MSPS for potential secondary structures that might
provide clues about their involvement in regulation. Both 3'-UTRs are
about 90% G+C+U, so unfortunately, when both G-C and G-U base pairing
are allowed, the number, sizes, and complexities of possible hairpin
loops in these 3'-UTRs of 1.0 and 1.3 kb are immense. Thus, these
secondary structure analyses were not informative, even when smaller
regions of the 3'-UTRs were examined (not shown). Therefore, the two
3'-UTRs were tested further for regulatory sequence elements by
deleting ~200-bp segments across the entire 3'-UTR using the SOE PCR
technique. In the case of the 3'-UTRPSAA, five
adjacent segments were individually deleted (Fig.
3) and the constructs, called
A
1-A
5, were cloned into
pX
GAL2 for stable transfection into virulent
promastigotes and subsequent analyses (Fig.
4). The right-hand boundary of the
deletion in construct A
5 was designed to occur 13 nucleotides upstream of the polyadenylation site to preserve this site.
Point mutations were introduced into SOE PCR primers so that a unique
restriction site, AvrII, would be present in recombinant
constructs at the site of the deletion. To determine whether changes in
GAL expression were merely due to changes in spacing
generated by deletions, the AvrII sites were used to insert
non-leishmanial DNA (from pBluescript) of the same length and GC
nucleotide content as the 200-bp deletion. This generated another
series of recombinant constructs called A
1link-A
5link. The plasmid deletion
constructs and their corresponding linker constructs were stably
transfected into promastigotes, and the
GAL activities in
logarithmic and stationary phase cells were analyzed. In every case the
GAL activities derived from a given 200-bp deletion
construct and its corresponding "link(er)" construct were found to
be equivalent within experimental error (not shown). Thus, Fig. 4 shows
the data for only the deletion constructs.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 3.
Sequences and locations of the SOE primers
used to create deletions in the 3'-UTRPSAA. Both
strands of the 3'-UTR are shown. The TGA stop codon is
boxed. The vertical arrow points to the
polyadenylation site. SOE PCR primers are shown with arrows
pointing in the 3' direction above or below their
corresponding sequences, which are shaded gray. The 5' tails
required for the SOE PCR amplification are shown as angled
lines with solid black circles extending off the
arrow.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
The 3'-UTRPSAA contains a
negative element in segment 1 and positive regulatory elements in
segments 3 and 4. The plasmids stably transfected into
promastigotes are depicted by schematic diagrams. Large open
rectangles indicate the GAL-coding region. Other
rectangles of different shades of gray represent different
segments of the 3'-UTRPSAA. Lines
after the rectangles depict the IR sequence. The segments
are numbered above the corresponding rectangle. The
letter A indicates an AvrII site. For each
construct, data were obtained from a minimum of three independent
experiments with each transfected cell line. The mean normalized
GAL S/L ratio was calculated as described under
"Experimental Procedures" and is represented by the mean value
±S.D. The mean normalized GAL S/L values for each
transfectant was recorded and compared with the mean normalized S/L
GAL value of the transfectant containing the wild type
3'-UTR. These calculations are recorded as fold differences
versus wild type and were performed using the Student's
t test to obtain a p value. Increases in the S/L
GAL ratio are shown by arrows pointing up;
decreases are shown by arrows pointing down. For example,
there is a 2.7-fold (or 81.3/30.5) increase in the mean normalized S/L
ratio in the transfectant containing A 1 compared with
wild type.
|
|
Deletion A
1 caused a 2.7-fold increase in the S/L
GAL ratio compared with the wild type (wt)
3'-UTRPSAA, suggesting there may be a negative control
element in this segment. Other deletions had no effect
(A
2) or caused a decrease (A
3, A
4, A
5) in the S/L ratio. Deletions
A
3 and A
4 exhibited the largest effects,
i.e. decreases of 11- and 15-fold in the S/L ratio,
respectively. Interestingly, these deleted segments flank olp, whose
deletion had no effect (compare Figs. 2 and 4). Thus, sequences deleted
in the A
3 and A
4 constructs possess a
positive control element(s) that increases
GAL activity
in stationary cells.
To further map putative positive regulatory elements, plasmid
constructs A
3A and A
3B were generated to
examine the individual effects of each half of segment 3. In each of
these constructs, a non-leishmanial sequence was introduced to preserve
the position of the wild type sequence within the 3'-UTR. To our
surprise, the presence of either half of segment 3 did not restore wild type
GAL activity in stationary phase (Fig. 4). A similar
half-deletion of segment 4 was not constructed.
The locations of the two nucleotide replacements in construct
A
3 that were used to create the AvrII site (5'
CCTAGG) at the site of the A
3 deletion are shown in Fig.
5. Insertion of a 200-bp linker sequence
into this site did not significantly change the
GAL S/L
ratio from that shown for A
3 in Fig. 4 (not shown). Surprisingly, however, re-insertion of the wild type segment 3 sequence
into the AvrII site also did not restore the wild type S/L
GAL ratio (Fig. 6, compare
A
3 and A
3wt). Because
the only difference between the A
3wt and PSAA
3'-UTR constructs is the AvrII site, we tested whether
the AvrII site itself might be responsible for this
unexpected result. Three additional constructs were prepared (Fig. 6).
To prepare construct A
3wt5', the SOE PCR primers were designed to eliminate the AvrII site on the 5' side of
segment 3 and retain it on the 3' side. In construct
A
3wt3', the AvrII site was eliminated on the
3' side of segment 3 and retained on the 5' side. Finally, in construct
A
3Avr(
), segment 3 was deleted from the
3'-UTRPSAA by SOE PCR without generation of an
additional AvrII site. In the resulting stable
transfectants, the wild type S/L
GAL ratio was restored
in construct A
3wt3' but not in construct
A
3wt5' (Fig. 6). Thus, replacement of two nucleotides to
generate an AvrII site at the segment 3-olp boundary of
A
3wt5' (Fig. 5) is sufficient to cause loss of
logarithmic-stationary regulation. However, when segment 3 was deleted
without the concomitant insertion of an AvrII site in
construct A
3Avr(
),the logarithmic-stationary regulation
of
GAL was abrogated even more completely than the A
3 construct (20.6-fold decrease versus
11.3-fold decrease). Thus, the presence of the non-mutated sequence at
the 3'-end of segment 3 alone is not sufficient to confer wild type
regulation.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison of the boundaries between segment
3 and olp in the 3'-UTRPSAA and 3'-UTRMSPS.
Vertical lines between nucleotides in the olp
(OLP) region indicate identical nucleotides. Diagonal
lines indicate five additional nucleotides of identity detected
after the experiments were conducted. The nucleotides mutated to
generate an AvrII site (5'-CCTAGG) in constructs
A 3 and S 3 are shown.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
Additional characterizations of the effect of
deletions of segment 3 and segment 4 in the
3'-UTRPSAA. Plasmids are depicted by schematic
diagrams as described in the legend for Fig. 4. The relative positions
of AvrII (A) sites are shown. The mean normalized
GAL S/L ratio was calculated as described in the legend
for Fig. 4 and under "Experimental Procedures." For example, there
is an 11.3-fold (or 30.5/2.70) decrease in the mean normalized S/L
ratio in the A 3 transfectants compared with wild type.
The data shown in Fig. 4 for the wild type construct and constructs
A 3 and A olp are also shown here for the
sake of comparison.
|
|
Because an AvrII site had also been engineered at the
deletion site in the A
4 construct (Figs. 4 and 6), the
segment 4 wild type sequence was also reinserted into this
AvrII site to generate construct A
4wt. In this
case and in contrast to construct A
3wt, the wild type S/L
GAL ratio was restored in A
4wt (Fig. 6).
Thus, the presence of the AvrII site does not appear to
alter regulation of
GAL expression in the
A
4 constructs as it does with the A
3 construct. Similarly, in experiments not shown, transfectants containing plasmid constructs in which only each end of segment 4 is
mutated to an AvrII site have wild type S/L
GAL ratios.
Specific Segments of the 3'-UTRMSPS Are
Also Involved in Gene Regulation--
A deletion analysis of the
1.0-kb 3'-UTRMSPS was also undertaken
similar to the 3'-UTRPSAA analysis (Figs.
7 and 8).
Four deletion constructs with deleted segments replaced by a single
AvrII site, called S
1-S
4, were cloned into pX
GAL2 and stably transfected into virulent
promastigotes. Also similar to the PSAA analysis, in each
case non-leishmanial DNA (from pBluescript) of the same size and GC
content as the deleted segment was cloned into the AvrII
site, producing a corresponding set of constructs called
S
1link-S
4link. As was found with the 3'-UTRPSAA, the S/L
GAL ratio of a
given deletion construct and its corresponding linker construct were
found to be the same within experimental error, so only the deletion
data are shown (Fig. 8).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 7.
Sequences and locations of the SOE primers
used to create deletions in the 3'-UTRMSPS. The
symbols are the same as indicated in the legend for Fig.
3.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Segments 3 and 4 of the
3'-UTRMSPS contain positive regulatory elements.
Plasmids are depicted by schematic diagrams as described in the legend
for Fig. 4. The mean normalized GAL S/L ratio was
calculated as described in the legend for Fig. 4 and under
"Experimental Procedures." For example, there is a 7.5-fold (or
62.5/8.37) decrease in the mean normalized S/L ratio in the
S 3 transfectants compared with wild type.
|
|
Deletion S
1 had no effect on the
GAL S/L
ratio compared with wild type, and S
2 resulted in only
about a 2-fold change. In contrast, S
3 and
S
4 caused 7.5- and 3.5-fold decreases in the S/L ratio,
respectively. Thus, similar to the 3'-UTRPSAA
data, deletions of the segments flanking the olp region exerted the
largest effects, and in both cases, the deletions caused a decrease of
the
GAL S/L ratio. Constructs S
3A and
S
3B were also generated to examine the effects of each
half of segment 3 (Fig. 8). Similar to the findings with
A
3A and A
3B (Fig. 4), the presence of either half of
segment 3 of the 3'-UTRMSPS did not restore the
wild type S/L ratio. Thus, the positive regulatory element(s) extends
across both halves of segment 3 of the
3'-UTRMSPS as it does in segment 3 of the
3'-UTRPSAA.
Because of the effects of the engineered AvrII site in some
of the 3'-UTRPSAA constructs, the wild type
segment 3 sequence was reinserted at the AvrII site of
construct S
3 to generate construct S
3wt.
Fig. 5 shows the three-nucleotide replacements that were generated during SOE PCR to create this AvrII site. In contrast to
A
3wt (Figs. 4 and 6), insertion of wild type segment 3 sequence into the AvrII site of S
3 restored
the wild type S/L
GAL ratio (S
3wt in Fig.
8). A similar restoration of wild type activity was obtained when the
wild type segment 4 sequence was replaced into the AvrII site of S
4 (not shown). Thus, the nucleotide replacements
used to create the AvrII site in these S
constructs do not affect expression of the upstream
GAL gene.
Insertion of Region 3 from the 3'-UTRPSAA Did Not
Restore Regulation in Construct S
3--
Because deletions of the
segments flanking the olp region in both
3'-UTRMSPS and 3'-UTRPSAA
had similar effects, we tested whether these segments in one 3'-UTR
could be replaced with the corresponding segments of the other 3'-UTR
and still retain the regulation. Therefore, PSAA segment 3 was inserted into the AvrII site of construct
S
3 to generate construct S
3-Awt3
(bottom of Fig. 8). In contrast to S
3wt, the
wild type S/L
GAL ratio of the
3'-UTRMSPS was not restored in
S
3-Awt3. Instead, the S/L ratio of the original S
3 dropped even further, i.e. from 7.5- to
22.2-fold. A similar result was obtained when PSAA segment 4 was inserted into construct S
4, i.e. the wild
type S/L
GAL ratio dropped still further instead of being
restored (data not shown). Therefore, in these two examples the
regulatory region of one 3'-UTR could not replace the correspondingly positioned regulatory region of the other 3'-UTR, suggesting that these
regulatory regions function only within the context of their own
3'-UTRs.
 |
DISCUSSION |
The purpose of the current work was to map sequences in the
3'-UTRs of two tandemly repeated gene classes of L. chagasi
whose mRNAs are expressed at similar times in the growth cycle of
the parasite. We hypothesized that similar molecular features would account for their similar patterns of expression. Our data revealed that the mechanisms regulating levels of MSPS and
GP46A RNAs are likely to be complex, involving at least
several regions of their 3'-UTRs. Furthermore, our data suggest that
different features of each of these 3'-UTR sequences regulate gene expression.
Many differentially expressed trypanosomatid genes are regulated
post-transcriptionally by molecular mechanisms involving their 3'-UTRs
(21-28, 40-42). The most extensively studied group of
post-transcriptionally regulated genes in trypanosomatids is the
T. brucei gene family encoding the related acidic repetitive proteins, EP and GPEET (previously called procyclic acidic repetitive protein or PARP (43)), found exclusively on the surface of the procyclic (insect) form of T. brucei (29, 30). The
coding regions of the EPs and GPEETs in the
T. brucei genome are similar, but their short 3'-UTRs (300 bp) share only a conserved 26-mer sequence. The 100-fold higher steady
state level of the EP and GPEET mRNAs in the
procyclic form than in the bloodstream form is controlled mainly by
elements in their 3'-UTRs (30, 44, 45). Deletion analysis of the
EP1 3'-UTR (30, 32) and characterization of its secondary
structure by RNase digestion and lead hydrolysis (31) indicate that
this 3'-UTR consists of three domains, I, II, and III. The 5' and 3'
domains I and III, respectively, form independent stem-loop structures
in the RNA, whereas the central domain II contains the conserved 26-mer
as a single-strand. Domains I and III both have positive regulatory
elements, and it has been proposed that in procyclic trypanosomes one
or more factors bind to these positive elements in the flanking
stem-loops, shielding domain II from endonuclease degradation. In
bloodstream trypanosomes, which presumably lack these positive
regulators, the single-stranded domain II is exposed to endonuclease
activity and quickly degraded (29, 31).
Similar to T. brucei EP and GPEET, Leishmania PSA
and MSP are the major surface glycoproteins on the insect form of
parasite, and these Leishmania and T. brucei
genes are post-transcriptionally regulated in a parallel manner via
their dissimilar 3'-UTR sequences. The extent to which the patterns of
cis-acting regulatory elements in the 3'-UTRs of their
mRNAs resemble each other is intriguing. Similar to the
EPs and GPEETs, PSAA and
MSPS are regulated in a parallel fashion by their 3'-UTRs,
yet these 3'-UTRs contain little sequence similarity. Likewise, similar
to domains I and III of the EP1 3'-UTR, segments 3 and 4 of
the PSAA and MSPS3'-UTRs contain positive
regulatory elements that flank a conserved region (domain II in the
EPs and olp in PSAA and MSPS). In the
3'-UTRPSAA, deletions of segments 3 and 4 result
in an 11- and 15-fold loss, respectively, in PSAA
up-expression in stationary phase (Fig. 4). In the
3'-UTRMSPS, deletions of segments 3 and 4 cause
a 7.5- and 3.5-fold drop, respectively, in MSPS
up-expression in stationary phase (Fig. 8). In both of these
Leishmania genes the positive regulatory element(s) in
segment 3 could not be further localized by deleting just the 5' or the
3' half of segment 3. Similarly, the positive regulatory element(s) in
domains I and III of the EP1 3'-UTR extend across the
stem-loop in most of the domain (30-32). The PSAA and MSPS data also suggest that the regulatory elements in
segments 3 and 4 are both necessary, but neither is sufficient to
confer full up-regulation of gene expression, again similar to
domains I and III of EP1. It is not known whether possible
hairpin loops in segments 3 and 4 of PSAA and
MSPS play the same roles as the hairpin loops in domains I
and III of the EP13'-UTR (31). The 200-nucleotide sequences
of segments 3 and 4 have potential hairpin loops, as detected by RNA
secondary structure prediction programs (not shown), but these
sequences are too long for the predictions to be reliable. RNase
digestion and lead hydrolysis experiments, similar to those conducted
on the EP1 3'-UTR (31), will be necessary to clarify this question.
Unexpectedly, when the sequence of segment 3 was reintroduced into the
engineered AvrII site in the A
3 deletion construct, wild
type activity was not restored (Fig. 6). However, when the sequence at
the 3' boundary but not at the 5' boundary of segment 3 was restored to
wild type (i.e. without the AvrII site), activity was restored to wild type level. Thus, the wild type context at the 3'
end of segment 3 is necessary for regulation of PSAA
stationary phase expression. However, it is not a sufficient regulatory
factor, since wild type regulation was not achieved by the presence of the wild type 3' end of segment 3 alone, as demonstrated by experiments with transfectants containing the A
Avr(
) deletion
construct (Fig. 6). This A
Avr(
) construct shows that
the two altered bases at the 3' end of segment 3 do not substitute for
the entire segment 3. Furthermore, the positive effect of segment 3 and
its wild type 3' sequence (Figs. 4-6) was active only when the olp
sequence was present. When the olp sequence was deleted,
A
olp, replacement of the two bases to generate the
AvrII site at the 3' end of segment 3 (Fig. 5) did not have
the negative effect on regulation that is demonstrated by
A
3wt and A
3wt5' (Fig. 6). These data are consistent with a model in which positive regulation by segment 3 results from shielding a negative element in the olp segment, such as a
degradation signal. When the degradation signal is absent, as in the
A
olp deletion construct, the protective effect of segment 3 is unnecessary, and wild type regulation is achieved. This is analogous to the involvement of domains I and II in the regulation of
EP/GPEET expression.
When segment 4 of 3'-UTRPSAA is deleted, there
is a 15-fold loss of regulation that can be restored by reintroduction
of wild type sequence into the engineered AvrII site (Fig.
6), again similar in this case to the involvement of domains II and III
in the regulation of EP/GPEET expression. Thus,
segments 3 and 4 are necessary but not sufficient alone for regulation
of PSAA gene expression. To determine whether these segments
interact, a construct in which both segments are deleted will be necessary.
In summary, the regulatory effects of the
3'-UTRPSSA and 3'-UTRMSPS
are clearly complex and multifaceted. Our data are consistent with a
model in which segment 1 of the 3'-UTRPSAA
contains a modest negative regulatory element, resulting in a 2.7-fold
negative regulatory effect. Segments 3 and 4 each contain positive
regulatory elements that appear to shield the olp region. Similarly,
the 3'-UTRMSPS contains positive regulatory
elements in segments 3 and 4 that flank the olp region, although there
does not appear to be a weak negative regulator in segment 1 as there
is in the 3'-UTRPSAA. Nucleotides at the
boundary between segment 3 and olp appear to be critical for
PSAA regulation, but we have no evidence for their
involvement in MSPS regulation (Figs. 5, 6, and 8). The AvrII site in the 3'-UTRPSAA
constructs was generated by two replacement mutations separated by a
single base pair, both of which are in segment 3. The AvrII site in the 3'-UTRMSPS was generated by three
replacements, one of which is in segment 3 and two of which are
adjacent to each other three base pairs downstream in the olp sequence.
Five additional adjacent nucleotides in segment 3 are shared between
the 3'-UTRPSAA and
3'-UTRMSPS, as indicated by the diagonal
lines in Fig. 5. All three replacements used to generate the
AvrII site in the 3'-UTRMSPS disrupt
identical nucleotides in the two 3'-UTRs, yet there was only an effect
on the regulation of PSAA3'-UTR constructs. It will be
worthwhile to determine whether these five nucleotides are important in
the regulation conferred by the 3'-UTRPSAA but
not 3'-UTRMSPS.
The similar features in the regulation of these Leishmania
genes and those of the T. brucei EP/GPEETs support the
possibility that there are common themes to the molecular mechanisms
determining post-transcriptional regulation of trypanosomatid gene
expression through sequences in their 3'-UTRs. Further elucidation of
these regulatory mechanisms will require an even more detailed
dissection of the 3'-UTR sequences and the potential proteins with
which they interact than has been undertaken to date.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants AI32135 and AI43050 and a Veterans Affairs Merit Review grant.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Dept. of Veterinary Pathology, Iowa State
University, Ames, IA 50011.
§§
To whom correspondence should be addressed. Tel.: 319-335-7934;
Fax: 319-353-4204; E-mail: john-donelson@uiowa.edu.
Published, JBC Papers in Press, February 20, 2002, DOI 10.1074/jbc.M200174200
 |
ABBREVIATIONS |
The abbreviations used are:
MSP, major surface
protease of 63 kDa;
PSA, parasite-specific antigen of 46 kDa;
UTR, untranslated region;
IR, intergenic region from the poly(A) addition
site of one gene to the ATG start codon of the downstream gene;
GAL,
-galactosidase;
SOE, spliced overlap extension;
RFU, relative fluorescence units;
olp, overlap region;
kb, kilobase(s);
S/L ratio, stationary/log ratio;
bp, base pair(s);
wt, wild type;
EP, dipeptide repeat protein;
GPEET, pentapeptide repeat protein.
 |
REFERENCES |
| 1.
|
Clayton, C.,
Adams, M.,
Almeida, R.,
Baltz, T.,
Barrett, M.,
Bastien, P.,
Belli, S.,
Beverley, S.,
Biteau, N.,
Blackwell, J.,
Blaineau, C.,
Boshart, M.,
Bringaud, F.,
Cross, G.,
Cruz, A.,
Degrave, W.,
Donelson, J., El-,
Sayed, N., Fu, G.,
Ersfeld, K.,
Gibson, W.,
Gull, K.,
Ivens, A.,
Kelly, J.,
Lawson, D.,
Lebowitz, J.,
Majiwa, P.,
Matthews, K.,
Melville, S.,
Merlin, G.,
Michels, P.,
Myer, P.,
Norrish, A.,
Opperdoes, F.,
Papadopoulou, B.,
Parsons, M.,
Seebeck, T.,
Smith, D.,
Stuart, K.,
Turner, M.,
Ullu, E.,
and Vanhamme, L.
(1998)
Mol. Biochem. Parasitol.
97,
221-224[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
McMahon-Pratt, D.,
Rodriguez, D.,
Rodriguez, J. R.,
Zhang, Y.,
Manson, K.,
Bergman, C.,
Rivas, L.,
Rodriguez, J. F.,
Lohman, K. L.,
Ruddle, N. H.,
and Esteban, M.
(1993)
Infect. Immun.
61,
3351-3359[Abstract/Free Full Text]
|
| 3.
|
Noormohammadi, A. H.,
Hochrein, H.,
Curtis, J. M.,
Balwin, T. M.,
and Handman, E.
(2001)
Vaccine
19,
4043-4053[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Handman, E.,
Noormohammadi, A. H.,
Curtis, J. M.,
Baldwin, T.,
and Sjolander, A.
(2000)
Vaccine
18,
3011-3017[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Frankenburg, S.,
Axelrod, O.,
Kutner, S.,
Greenblatt, C. L.,
Klaus, S. N.,
Pirak, E. A.,
McMaster, W. R.,
and Lowell, G. H.
(1996)
Vaccine
14,
923-929[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Olobo, J. O.,
Anjili, C. O.,
Gicheru, M. M.,
Mbati, P. A.,
Kariuki, T. M.,
Githure, J. I.,
Koech, D. K.,
and McMaster, W. R.
(1995)
Vet. Parasitol.
60,
199-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Brittingham, A.,
Morrison, C. J.,
McMaster, W. R.,
McGwire, B. S.,
Chang, K. P.,
and Mosser, D. M.
(1995)
J. Immunol.
155,
3102-3111[Abstract]
|
| 8.
|
Russell, D. G.,
and Wilhelm, H.
(1986)
J. Immunol.
136,
2613-2626[Abstract]
|
| 9.
|
Seay, M. B.,
Heard, P. L.,
and Chaudhuri, G.
(1996)
Infect. Immun.
64,
5129-5137[Abstract]
|
| 10.
|
Wilson, M. E.,
Hardin, K. K.,
and Donelson, J. E.
(1989)
J. Immunol.
143,
678-684[Abstract]
|
| 11.
|
Kweider, M.,
Lemesre, J. L.,
Santoro, F.,
Kusinerz, J. P.,
Sadigurzky, M.,
and Capron, A.
(1989)
Parasite Immunol. (Oxf.)
148,
197-209
|
| 12.
|
Brittingham, A.,
Miller, M. A.,
Donelson, J. E.,
and Wilson, M. E.
(2001)
Mol. Biochem. Parasitol.
112,
51-59[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Roberts, S. C.,
Swihart, K. G.,
Agey, M. W.,
Ramamoorthy, R.,
Wilson, M. E.,
and Donelson, J. E.
(1993)
Mol. Biochem. Parasitol.
62,
157-172[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Ramamoorthy, R.,
Donelson, J. E.,
Paetz, K. E.,
Maybodi, M.,
Roberts, S. C.,
and Wilson, M. E.
(1992)
J. Biol. Chem.
267,
1888-1895[Abstract/Free Full Text]
|
| 15.
|
Kahl, L. P.,
and MacMahon-Pratt, D.
(1987)
J. Immunol.
138,
1587-1595[Abstract]
|
| 16.
|
Murray, P.,
Spithill, T.,
and Handman, E.
(1989)
J. Immunol.
143,
4221-4226[Abstract]
|
| 17.
|
MaMohon-Pratt, D.,
Traub-Cseko, Y.,
Lohman, K. L.,
Rogers, D. D.,
and Beverley, S. M.
(1992)
Mol. Biochem. Parasitol.
50,
151-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Symons, F. M.,
Murray, P. J., Ji, H.,
Simpson, R. J.,
Osborn, A. H.,
Cappai, R.,
and Handman, E.
(1994)
Mol. Biochem. Parasitol.
67,
103-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Jimenez-Ruiz, A.,
Boceta, C.,
Bonay, P.,
Requuena, J. M.,
and Alonso, C.
(1998)
Eur. J. Biochem.
251,
389-397[Medline]
[Order article via Infotrieve]
|
| 20.
|
Beetham, J. K.,
Myung, K. S.,
McCoy, J. J.,
Wilson, M. E.,
and Donelson, J. E.
(1997)
J. Biol. Chem.
272,
17360-17366[Abstract/Free Full Text]
|
| 21.
|
Graham, S. V.
(1995)
Parasitol. Today
11,
217-223[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Aly, R.,
Argaman, M.,
Halman, S.,
and Shapira, M.
(1994)
Nucleic Acids Res.
22,
2922-2929[Abstract/Free Full Text]
|
| 23.
|
Nozaki, T.,
and Cross, G. A. M.
(1995)
Mol. Biochem. Parasitol.
75,
55-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Teixeira, S. M. R.,
Kirchhoff, L. V.,
and Donelson, J. E.
(1995)
J. Biol. Chem.
270,
22586-22594[Abstract/Free Full Text]
|
| 25.
|
Coughlin, B. C.,
Teixeira, S. M. R.,
Kirchhoff, L. V.,
and Donelson, J. E.
(2000)
J. Biol. Chem.
275,
12051-12060[Abstract/Free Full Text]
|
| 26.
|
Kelly, B. L.,
Nelson, T. N.,
and McMaster, W. R.
(2001)
Mol. Biochem. Parasitol
116,
101-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Charest, H.,
Zhang, W.-W.,
and Matlashewski, G.
(1996)
J. Biol. Chem.
271,
17081-17090[Abstract/Free Full Text]
|
| 28.
|
Quijada, L.,
Soto, M.,
Alonso, C.,
and Requena, J. M.
(2000)
Mol. Biochem. Parasitol.
110,
79-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Roditi, I.,
Furger, A.,
Ruepp, S.,
Schürch, N.,
and Bütikofer, P.
(1998)
Mol. Biochem. Parasitol.
91,
117-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Hotz, H.-R.,
Biebinger, S.,
Flaspohler, J.,
and Clayton, C.
(1998)
Mol. Biochem. Parasitol.
91,
131-143[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Drozdz, M.,
and Clayton, C.
(2000)
RNA (N. Y.)
5,
1632-1644[Abstract]
|
| 32.
|
Furger, A.,
Schürch, N.,
Kurath, U.,
and Roditi, I.
(1997)
Mol. Cell. Biol.
17,
4372-4380[Abstract]
|
| 33.
|
LeBowitz, J. H.
(1994)
Methods Cell Biol.
45,
65-78[Medline]
[Order article via Infotrieve]
|
| 34.
|
Zarley, J. H.,
Britigan, B. E.,
and Wilson, M. E.
(1991)
J. Clin. Invest.
88,
1511-1521[Medline]
[Order article via Infotrieve]
|
| 35.
| Deleted in proof
|
| 36.
|
LeBowitz, J. H.,
Coburn, C. M.,
MacMahon-Pratt, D.,
and Beverley, S. M.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
9736-9740 |